News

Icon, Computational Health, Featured Publication

Researchers at Helmholtz Munich have found that the body begins signaling the risk of type 2 diabetes many years before the disease is diagnosed. In a long-term study, the team examined hundreds of blood metabolites – small molecules that reflect…

Helmholtz Munich is part of the EU research initiative PROBE, which aims to fundamentally transform the way osteoarthritis is diagnosed and treated. The project is funded through HORIZON EUROPE by the Innovative Health Initiative and has a total…

Helmholtz Munich has secured funding in the Helmholtz Association’s first-ever “UNLOCK” call for AI benchmarking. With three projects approved, the center plays a key role in developing high-quality, multimodal benchmarking datasets that will improve…

Scientists at Helmholtz Munich, together with Harvard Medical School and international collaborators, have developed TITAN, an artificial intelligence (AI) model capable of analyzing and describing digital pathology slides. By combining information…

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial transcriptomics. Trained on more than 110 million cells,…

Helmholtz Munich had the pleasure to welcome Prof. Eric Topol, internationally recognized cardiologist, geneticist, and digital medicine expert, for a roundtable on the future of AI in healthcare. The event, serving as a prologue to the Bavarian…

News

Tracking Metabolic Clues Years Before Type 2 Diabetes Develops

Helmholtz Munich Launches Pioneering Osteoarthritis Research Project With EU Partners

Helmholtz Munich to Advance AI Benchmarking With Three Newly Funded Projects

TITAN: A Multimodal AI Model for Digital Pathology Slides

New Foundation Model Reveals How Cells Are Organized in Tissues

Prof. Eric Topol Visits Helmholtz Munich for Roundtable on “Virtual Human”